InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the full record of transactions filed by Venkataraman Sriram. Director active across 1 company, notably RVL Pharmaceuticals plc. Cumulatively, 2 filings have been published. Split: 1 buy · 0 sell. Total volume traded: €12.2m. History available since 8 August 2022. The latest transaction was disclosed on 27 January 2023 (J). Regulator: SEC (Form 4). All data is accessible without signup.
2 of 2 declarations